| 摘要 |
A method of inhibiting endometrial cancer comprising administering to a human in need thereof an effective amount of a compound having formula (I) wherein R<1> and R<3> are independently hydrogen, -CH3, (a), or (b), wherein Ar is optionally substituted phenyl; R<2> is selected from the group consisting of pyrrolidine, hexamethyleneimino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
|
